Posted by jrbecker on October 8, 2002, at 13:34:11
In reply to Re: norepinephrine uptake inhibitors (help please!) » SLS, posted by Ritch on October 8, 2002, at 8:58:46
back in my days in advertising, I was privy to a lot of the research data on tomoxetine (atomoxetine), since my agency was in a bid to get the advetising account for the drug when it started its marketing campaign. The data looked great. It is much subtler than the stimulants and supposedly much more of an alternative ADHD preferred treatment in comparison to other ADs. Lilly is really excited about this drug and so is my own pdoc for congruency in my own therapeutic regimen for atypcial dep. I have moderate problems with focus and motivation, largely from the fact that NE is highly associated with atypical depression's etiology.
It will launch in early '03.
poster:jrbecker
thread:122549
URL: http://www.dr-bob.org/babble/20021006/msgs/122769.html